Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Oct 29, 2010

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genetics services contract research company Emerald Biostructures has formed a scientific advisory board that includes John Hunt, John McCall, John Mulligan, and Lynn Silver.

Hunt is co-director of the crystallography group at Northeast Structural Genomics and a faculty member of Columbia University; McCall is president of PharMac and has worked at Pharmacia, Pfizer, co-founded VBPharma, and served on boards at the Michigan High Throughput Screening Center and other entities; Mulligan is founder and former CEO of Blue Heron Biotechnology and co-founder of the International Gene Synthesis Consortium; Silver worked for two decades at Merck Research Laboratories.

Response Biomedical said this week that Duane Morris has resigned from his post as chief operating officer of the firm, where he has worked for four years. The company noted that it has undertaken a “major restructuring and refocusing” on its cardiovascular business.

Health Discovery Corporation has appointed Thomas Gallagher to be company president, COO, and general counsel, in addition to continuing to serving in his current roles. Gallagher joined the firm a year ago as executive VP and managing director of global IP strategies. The company’s board of directors has agreed to give Gallagher 2.5 million purchase options for its common stock, a base salary of $120,000, and a potential bonus of $120,000.

Signal Genetics has appointed five people to serve on its scientific advisory board, including Kenneth Anderson, Keith Stewart, David Gelfand, Cynthia French, and Craig Keyes.

Anderson is director of the Jerome Lipper Multiple Myeloma Center at the Dana-Farber Cancer Institute and Kraft Family professor of medicine at Harvard Medical School; Keith Stewart is professor of medicine at the Mayo Clinic; Gelfand is chief scientific officer at WaferGen Biosystems, has worked previously at Roche Molecular Systems, and he has received attention as an inventor for Taq DNA Polymerase; French recently was CSO at Exiqon, and she has worked at Affymetrix and Quest; Keyes was president and CEO of UnitedHealthcare of Colorado and CEO of UnitedHealthcare of New York Tri-State, among other management positions.

Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.